Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Genome Medicine
|
May 16, 2013
Assessing biomarkers for brain diseases: progress and gaps
Linda S Brady
Psychopharmacology
|
November 25, 2016
Athina Markou's contributions to treatment development for mental illnesses: a perspective
Lois Winsky, Linda S Brady
Expert Opinion on Drug Discovery
|
December 7, 2013
Public-private partnerships to revitalize psychiatric drug discovery
Linda S Brady, William Z Potter
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 10, 2013
Proteomic biomarkers for brain disorders: technical considerations and challenges
Linda S Brady, William Z Potter
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
January 14, 2023
Accelerating Medicines Partnership<sup>®</sup> Schizophrenia (AMP<sup>®</sup> SCZ): developing tools to enable early intervention in the psychosis high risk state
Linda S Brady, Carlos A Larrauri,
CNS Spectrums
|
February 26, 2014
Current drug development for antidepressants and ideas addressing downstream glutamate: the ketamine example
William Z Potter, Linda S Brady
Advances in Neurobiology
|
November 19, 2024
Biomarker Methodologies: A NIMH Perspective
Margaret C Grabb, Linda S Brady
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 14, 2011
Translating discoveries into medicine: psychiatric drug development in 2011
Linda S Brady, Thomas R Insel
Molecular Pharmacology
|
April 5, 2007
Building a pharmacological lexicon: small molecule discovery in academia
John S Lazo, Linda S Brady, Ray Dingledine
Expert Opinion on Drug Discovery
|
September 24, 2019
Redirecting the revolution: new developments in drug development for psychiatry
Linda S Brady, William Z Potter, Joshua A Gordon
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Genome Medicine
|
May 16, 2013
Assessing biomarkers for brain diseases: progress and gaps
Linda S Brady
Psychopharmacology
|
November 25, 2016
Athina Markou's contributions to treatment development for mental illnesses: a perspective
Lois Winsky, Linda S Brady
Expert Opinion on Drug Discovery
|
December 7, 2013
Public-private partnerships to revitalize psychiatric drug discovery
Linda S Brady, William Z Potter
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 10, 2013
Proteomic biomarkers for brain disorders: technical considerations and challenges
Linda S Brady, William Z Potter
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
January 14, 2023
Accelerating Medicines Partnership<sup>®</sup> Schizophrenia (AMP<sup>®</sup> SCZ): developing tools to enable early intervention in the psychosis high risk state
Linda S Brady, Carlos A Larrauri,
CNS Spectrums
|
February 26, 2014
Current drug development for antidepressants and ideas addressing downstream glutamate: the ketamine example
William Z Potter, Linda S Brady
Advances in Neurobiology
|
November 19, 2024
Biomarker Methodologies: A NIMH Perspective
Margaret C Grabb, Linda S Brady
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 14, 2011
Translating discoveries into medicine: psychiatric drug development in 2011
Linda S Brady, Thomas R Insel
Molecular Pharmacology
|
April 5, 2007
Building a pharmacological lexicon: small molecule discovery in academia
John S Lazo, Linda S Brady, Ray Dingledine
Expert Opinion on Drug Discovery
|
September 24, 2019
Redirecting the revolution: new developments in drug development for psychiatry
Linda S Brady, William Z Potter, Joshua A Gordon
Page
of 2